Nouscom will present at Biocapital Europe - Nouscom

Nouscom will present at Biocapital Europe

Find out the full program here: http://www.biocapitaleurope.com

Recent Posts

Nouscom demonstrates Preclinical Proof of Concept for Personalized Cancer Neoantigen Vaccine in combination with Immune Checkpoint Blockade to Eradicate Large Tumors
IND for NOUS-209, an ‘off-the-shelf’ Neoantigen Cancer Vaccine, Cleared by FDA to Commence Clinical Development in MSI Solid Tumors
Dr. Marina Udier, COO of Nouscom, will give a talk about our company at the BaselArea.swiss Life Science Event on June 20, 2019 in Basel
Nouscom will present at the NeoAg Summit 2018